Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 8/20 | 0.70 |
| ▸ | MAPT | P10636 | 8/20 | 0.70 |
| ▸ | MEN1 | O00255 | 7/20 | 0.70 |
| ▸ | FLT3 | P36888 | 6/20 | 0.70 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.70 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.70 |
| ▸ | MAOB | P27338 | 5/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.70 |
| ▸ | ABCB1 | P08183 | 5/20 | 0.70 |
| ▸ | FTO | Q9C0B1 | 5/20 | 0.70 |
| ▸ | XDH | P47989 | 5/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.70 |
| ▸ | NPC1 | O15118 | 4/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.70 |
| ▸ | GABRP | O00591 | 4/20 | 0.70 |
| ▸ | GABRD | O14764 | 4/20 | 0.70 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.70 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.70 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hinokiflavone SCHEMBL30063752 | 1.00 | KMT2A (0.70) | KMT2AMAPTMEN1FLT3CYP1A1 | |
| SCHEMBL13485654 | 0.90 | QPCT (0.80) | KMT2AMAPTMEN1FLT3CYP1A1 | |
| SCHEMBL13672776 | 0.89 | XDH (0.67) | KMT2AMAPTMEN1FLT3CYP1A1 | |
| SCHEMBL13485651 | 0.88 | MAPT (0.72) | KMT2AMAPTMEN1FLT3CYP1A1 | |
| Hinokiflavone SCHEMBL4649967 | 0.88 | MAPT (0.66) | KMT2AMAPTMEN1FLT3CYP1A1 | |
| SCHEMBL30192733 | 0.87 | CYP1B1 (0.80) | KMT2AMAPTMEN1FLT3CYP1A1 | |
| SCHEMBL19715996 | 0.84 | CYP3A4 (0.67) | KMT2AMAPTMEN1FLT3CYP1A1 | |
| Apigenin SCHEMBL19428 | 0.84 | KMT2A (1.00) | KMT2AMAPTMEN1FLT3CYP1A1 | |
| Apigenin SCHEMBL29351464 | 0.84 | KMT2A (1.00) | KMT2AMAPTMEN1FLT3CYP1A1 | |
| Apigenin SCHEMBL5083245 | 0.84 | KMT2A (1.00) | KMT2AMAPTMEN1FLT3CYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 588 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| US-20260021167-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING NEURODEGENERATIVE DISEASES | DELAWARE STATE UNIVERSITY (US) | 2026-01-22 | — | — | US | claimed |
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) | 2025-11-06 | — | — | US | claimed |
| US-20250262233-A1 | COMPOSITION | SpecNova LLC (US) | 2025-08-21 | — | — | US | claimed |
| EP-2603098-B1 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER | FIRMENICH INCORPORATED (US) | 2025-08-06 | — | — | EP | claimed |
| EP-4540406-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING NEURODEGENERATIVE DISEASES | Kim, Yong Hwan (US) | 2025-04-23 | — | — | EP | claimed |
| WO-2024220449-A9 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2025-04-03 | — | — | WO | claimed |
| WO-2025024478-A1 | COMPOSITIONS FOR THE MODULATION OF TASTE | IXORA SCIENTIFIC INC. (US) | 2025-01-30 | — | — | WO | claimed |
| WO-2024220449-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | ASKLEPIOS BIOPHARMACEUTICAL, INC. (US) | 2024-10-24 | — | — | WO | claimed |
| WO-2023244772-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING NEURODEGENERATIVE DISEASES | KIM YONG HWAN (US) | 2023-12-21 | — | — | WO | claimed |
| US-20020068757-A1 | Biflavanoids and derivatives thereof as antiviral agents | ADVANCED LIFE SCIENCES, INC. | 2002-06-06 | — | — | US | claimed |
| US-6399654-B1 | ADMINISTERING MIXTURE OF VIRICIDE AND BIOFLAVANOID | ADVANCED LIFE SCIENCES, INC. | 2002-06-04 | — | — | US | claimed |
| US-20010031735-A1 | Flavonoide esters and their use notably in cosmetics | COLETICA (FR) | 2001-10-18 | — | — | US | claimed |
| CN-1290349-A | Pharmaceutical grade ginkgo biloba | PHARMAPRINT INC (US) | 2001-04-04 | — | — | CN | claimed |
| EP-1027603-A2 | PHARMACEUTICAL GRADE GINKGO BILOBA | Pharmaprint, Inc. (US) | 2000-08-16 | — | — | EP | claimed |
| WO-1999020291-A9 | PHARMACEUTICAL GRADE GINKGO BILOBA | PHARMAPRINT INC (US) | 1999-08-12 | — | — | WO | claimed |
| WO-1999020291-A2 | PHARMACEUTICAL GRADE GINKGO BILOBA | PHARMAPRINT, INC. (US) | 1999-04-29 | — | — | WO | claimed |
| WO-1998046238-A1 | BIFLAVINOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS, ALONE OR IN COMBINATION WITH AT LEAST ONE KNOWN ANTIVIRAL AGENT | MEDICHEM RESEARCH, INC. (US) | 1998-10-22 | — | — | WO | claimed |
| EP-0833631-A1 | BIFLAVANOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS | MEDICHEM RESEARCH, INC. (US) | 1998-04-08 | — | — | EP | claimed |
| WO-1997000679-A1 | BIFLAVANOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS | MEDICHEM RESEARCH, INC. (US) | 1997-01-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021167-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING NEURODEGENERATIVE DISEASES | SENP1, SUMO1, SUMO2 | KMT2A 2862/4885MAPT 291/4885MEN1 2529/4885 |
| US-20010031735-A1 | Flavonoide esters and their use notably in cosmetics | TYR, MITF, CYP2F1 | KMT2A 1023/4885MAPT 2248/4885MEN1 674/4885 |
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | S100A8, TP53, AQP1 | KMT2A 4248/4885MAPT 259/4885MEN1 312/4885 |
| US-20020068757-A1 | Biflavanoids and derivatives thereof as antiviral agents | HK2, GYS2, HK1 | KMT2A 463/4885MAPT 3337/4885MEN1 836/4885 |
| US-20250262233-A1 | COMPOSITION | GNG2, DSTN, PRSS12 | KMT2A 4489/4885MAPT 2074/4885MEN1 1696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.